Table of contents
October 2023 - Volume 61 - 10
Editorial
- Taxing ill health (28 August, 2023)
DTB Select
- FDA-approved drugs not meeting primary endpoints (24 August, 2023)
- Hydroxychloroquine and retinopathy risk (23 August, 2023)
Review
- Intravenous vitamin injections: where is the evidence? (28 August, 2023)
Republished case report
- Valacyclovir-associated acute kidney injury (30 June, 2023)
DTB commentary